BATON ROUGE, La.–(Business Wire)–
Amedisys, Inc. (NASDAQ: AMED), one of America’s leading home care and hospice
companies, announced today that James (Jim) T. Robinson, most recently of
American CareSource Holdings, Inc., has joined Amedisys as the Company`s new
Executive Vice President of Hospice.

“Jim brings a unique combination of skills and healthcare experience to Amedisys
and is going to be an excellent addition to our senior executive team,” stated
William F. Borne, Amedisys Chief Executive Officer. “His track record in growing
hospice programs combined with his breadth of knowledge in building and growing
healthcare companies strengthens our hospice management team. We`re counting on
Jim to provide the leadership, knowledge and creativity required to help
Amedisys become the leading provider of comprehensive in-home end-of-life care
and hospice services in the country.”

Over the past 20 years, Mr. Robinson has been on the leading edge of healthcare
innovation and has either led or has been a member of the senior management team
of five healthcare companies spanning cardiovascular medical devices; e-health;
physician-to-patient communication; pharmaceutical CRM services; end of life and
hospice care; alternative care delivery sites; and payor cost containment
services. In his role as Executive Vice President of Amedisys` Hospice business
unit, Mr. Robinson will be responsible for the growth and overall performance of
the company`s hospice organization.

“I`m very excited about joining Amedisys at this time,” said Mr. Robinson.
“Amedisys is uniquely positioned to provide a full continuum of cost-effective,
compassionate, comprehensive health care from the time a patient becomes a high
utilizer of healthcare services to the end-of-life. And by linking our growing
hospice programs to Amedisys` home health agencies in communities all across the
country, we should be able to grow our hospice census significantly over the
next several years and provide streamlined, seamless care at home to our
patients and their families.”

From 2006 to 2008, Mr. Robinson served as Executive Vice President and Chief
Marketing Officer of VistaCare, Inc., where he helped lead the turnaround and
eventual sale of the $230 million nationwide hospice/healthcare services company
to Odyssey HealthCare.

Prior to joining VistaCare, Mr. Robinson was President & CEO of HealthBanks,
Inc., an innovative, private-equity backed e-Health Network Company that
connects specialty physicians to their patients. Before HealthBanks, he was
co-founder of Avicenna Systems Corporation, a venture capital backed e-health
physician practice solutions company that was acquired by WebMD. Mr. Robinson
has also held a variety of management positions with St. Jude Medical, Inc.,
Hewlett Packard Medical Systems, and the Xerox Corporation. He earned a Bachelor
of Arts from Connecticut College and holds an MBA from Harvard University.

Amedisys, Inc. is headquartered in Baton Rouge, Louisiana. Its common stock
trades on the NASDAQ Global Select Market under the symbol “AMED.”

This press release includes statements that may constitute “forward-looking”
statements, usually containing the words “believe,” “estimate,” “project,”
“expect,” “anticipate” or similar expressions.Forward-looking statements
inherently involve risks and uncertainties that could cause actual results to
differ materially from the forward-looking statements.Many of the factors that
could cause or contribute to such differences are described in the Company`s
periodic reports and registrations statements filed with the Securities and
Exchange Commission, and include, but are not limited to the following: general
economic and business conditions, changes in or failure to comply with existing
regulations or the inability to comply with new government regulations on a
timely basis, changes in Medicare and other medical reimbursement levels,
ability to complete acquisitions announced from time to time, and any financing
related thereto, the ability to meet debt service requirements and to comply
with covenants in debt agreements, adverse changes in federal and state laws
relating to the health care industry, demographic changes, availability and
terms of capital, ability to attract and retain qualified personnel, ongoing
development and success of new start-ups, ability to successfully integrate
newly acquired agencies, changes in estimates and judgments associated with
critical accounting policies, business disruption due to natural disasters or
acts of terrorism, and various other matters, many of which are beyond
management`s control. By making these forward-looking statements, the Company
undertakes no obligation to update these statements for revisions or changes
after the date of this release.

Our company website address is www.amedisys.com. We use our website as a channel
of distribution for important company information. Important information,
including press releases, analyst presentations and financial information
regarding the Company is routinely posted on and accessible on the “Investor
Relations” subpage of our website, which is accessible by clicking on the tab
labeled “Investors” on our website home page.We will also use our website to
expedite public access to time-critical information regarding the Company in
advance of or in lieu of distributing a press release or a filing with the
Securities and Exchange Commission (“SEC”) disclosing the same information.In
addition, we make available on the Investor Relations subpage of our website
(under the link “SEC filings”) free of charge our annual reports on Form 10-K,
quarterly reports on Form 10-Q, current reports on Form 8-K, ownership reports
on Forms 3, 4 and 5 and any amendments to those reports as soon as practicable
after we electronically file such reports with the SEC. Further, copies of our
Certificate of Incorporation and Bylaws, our Code of Ethical Business Conduct
and the charters for the Audit, Compensation and Nominating and Governance
Committees of our Board are also available on the Investor Relations subpage of
our website (under the link “Corporate Governance”).

www.amedisys.com

Amedisys, Inc.
Kevin B. LeBlanc, 225-292-2031
Director of Investor Relations
kleblanc@amedisys.com

Copyright Business Wire 2010